/

Chong Chen1, Zixuan Wei2,3,4,5

  • 1Department of Clinical Laboratory, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.

Frontiers in oncology
|March 21, 2025
PubMed
概括

儿童复发性/耐药性神经母细胞瘤的预后不佳,原因是 MYCN 放大等复杂的分子变化. 了解这些机制是开发有针对性的精密治疗的关键.